Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Clot Management Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type
6.1 Neurovascular Embolectomy Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Embolectomy Balloon Catheters
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Percutaneous Thrombectomy Devices
6.3.1 Market Trends
6.3.2 Major Types
6.3.2.1 Mechanical Thrombectomy
6.3.2.2 Aspiration Thrombectomy
6.3.2.3 Percutaneous Mechanical Thrombectomy (PMT)
6.3.3 Market Forecast
6.4 Catheter-Directed Thrombolysis Devices
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Inferior Vena Cava Filters
6.5.1 Market Trends
6.5.2 Major Types
6.5.2.1 Permanent
6.5.2.2 Retrievable
6.5.3 Market Forecast

7 Market Breakup by End-User
7.1 Hospitals
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Diagnostic Centers and Specialty Clinics
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast

9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Indicators

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 AngioDynamics Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Argon Medical Devices Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Boston Scientific Corporation
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 DePuy Synthes Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 Edwards Lifesciences Corporation
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 iVascular S.L.U.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.7 Lemaitre Vascular Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Medtronic Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 Straub Medical AG
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.10 Stryker Corporation
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Teleflex Incorporated
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
13.3.12 Vascular Solutions
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio